Optellum is a lung health company, providing artificial intelligence solutions for clinicians (interventional pulmonologists, radiologists, nurse navigators and thoracic specialists). We offer the world's first and only AI-based lung cancer decision support software; FDA and CE-mark cleared.
Optellum Virtual Nodule Clinic assists Nodule Clinic Teams with:
• Patient Discovery AI: Helps nurse navigators and pulmonologists with automated identification of patients with reported nodules using Natural Language Processing (NLP).
• Tracking and Management: Provides nodule clinic specialists with an easy to use interface with longitudinal management and analytics.
• Lung Cancer Prediction AI: Helps pulmonologists with optimal clinical decisions driving earlier cancer treatment and fewer invasive procedures on benign nodules.
• Reimbursement: The Lung Cancer Prediction solution is reimbursable under New Technology Ambulatory Payment Classification for Medicare patients in the USA.
Virtual Nodule Clinic is used by leading healthcare systems in the US and the UK. The company also has strategic partnerships with GE Healthcare, Johnson & Johnson and TeraRecon.